Skip to main content
. 2020 Jun 11;12(6):542. doi: 10.3390/pharmaceutics12060542

Figure 5.

Figure 5

Schematic representation of some microfluidic models for neurodegenerative diseases, namely: (a) Alzheimer’s disease, (b) Multiple sclerosis, (c) Huntington’s disease. Reprinted and adapted with permission from: (a) Cho et al. [88], (b) Hosmane et al. [105], (c) Virlogeux et al. [113].